Zobrazeno 1 - 10
of 314
pro vyhledávání: '"Benjamin, Hibbert"'
Autor:
Cameron Stotts, BSc, Richard G. Jung, MD, PhD, Graeme Prosperi-Porta, MD, Pietro Di Santo, MD, Omar Abdel-Razek, MD, Simon Parlow, MD, F. Daniel Ramirez, MD, MSc, Trevor Simard, MD, Marino Labinaz, MD, Baylie Morgan, RN, Lisa Robinson, RN, Rebecca Mathew, MD, Benjamin Hibbert, MD, PhD
Publikováno v:
CJC Open, Vol 6, Iss 2, Pp 122-132 (2024)
Background: Type I myocardial infarction (T1MI) or type II myocardial infarction (T2MI) have different underlying mechanisms; however, in the setting of cardiogenic shock (CS), it is not understood if patients experience resultantly different outcome
Externí odkaz:
https://doaj.org/article/8278f736b8e74f35ae128faecdeb8004
Autor:
David Moher, Kelly D Cobey, Benjamin Hibbert, Sanam Ebrahimzadeh, Mohsen Alayche, Sara Saba, Nana Yaa Barnes, Emilio Alarcón
Publikováno v:
Open Heart, Vol 11, Iss 1 (2024)
Objective Open science is a movement and set of practices to conduct research more transparently. Implementing open science will significantly improve public access and supports equity. It also has the potential to foster innovation and reduce duplic
Externí odkaz:
https://doaj.org/article/ab4b621461cd416bbda9a98ad05b6d06
Autor:
Pouya Motazedian, Jeffrey A. Marbach, Graeme Prosperi-Porta, Simon Parlow, Pietro Di Santo, Omar Abdel-Razek, Richard Jung, William B. Bradford, Miranda Tsang, Michael Hyon, Stefano Pacifici, Sharanya Mohanty, F. Daniel Ramirez, Gordon S. Huggins, Trevor Simard, Stephanie Hon, Benjamin Hibbert
Publikováno v:
npj Digital Medicine, Vol 6, Iss 1, Pp 1-7 (2023)
Abstract Focused cardiac ultrasound (FoCUS) is becoming standard practice in a wide spectrum of clinical settings. There is limited data evaluating the real-world use of FoCUS with artificial intelligence (AI). Our objective was to determine the accu
Externí odkaz:
https://doaj.org/article/56473481782744538db8382c211d65a4
Autor:
Trevor Simard, Richard Jung, Pietro Di Santo, Alisha Labinaz, Spencer Short, Pouya Motazedian, Shan Dhaliwal, Dhruv Sarma, Adil Rasheed, F. Daniel Ramirez, Michael Froeschl, Marino Labinaz, David R. Holmes, Mohamad Alkhouli, Benjamin Hibbert
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
IntroductionPatients undergoing coronary stent implantation incur a 2% annual rate of adverse events, largely driven by in-stent restenosis (ISR) due to neointimal (NI) tissue proliferation, a process in which smooth muscle cell (SMC) biology may pla
Externí odkaz:
https://doaj.org/article/aa59808e112b41c6b41942f41a9058af
Autor:
Omar Abdel-Razek, MD, MSc, Pietro Di Santo, MD, Richard G. Jung, MD, PhD, Simon Parlow, MD, Pouya Motazedian, MD, Graeme Prosperi-Porta, MD, Sarah Visintini, MLIS, Jeffrey A. Marbach, MBBS, MSc, F. Daniel Ramirez, MD, MSc, Trevor Simard, MD, Marino Labinaz, MD, Rebecca Mathew, MD, Benjamin Hibbert, MD, PhD
Publikováno v:
Critical Care Explorations, Vol 5, Iss 9, p e0962 (2023)
OBJECTIVES:. Inotropic support is commonly used in patients with cardiogenic shock (CS). High-quality data guiding the use of dobutamine or milrinone among this patient population is limited. We compared the efficacy and safety of these two inotropes
Externí odkaz:
https://doaj.org/article/48cf283ebf394067b1dbfcdc59844740
Autor:
Dean A Fergusson, George A Wells, Kwadwo Kyeremanteng, Simon Parlow, Doug Coyle, Lisa Robinson, Cheng Yee Goh, Pietro Di Santo, Trevor Simard, Richard Jung, Jordan Bernick, Benjamin Hibbert, Omar Abdel-Razek, Marino Labinaz, Anthony Poulin, Baylie Morgan, Hannah Feagan, Jilliane Wade, Kuljit Singh, Michael Froeschl, Joseph Abunassar
Publikováno v:
BMJ Open, Vol 13, Iss 5 (2023)
Introduction Transradial access (TRA) has rapidly emerged as the preferred vascular access site for coronary angiography and percutaneous coronary intervention. Radial artery occlusion (RAO) remains as an important complication of TRA as it precludes
Externí odkaz:
https://doaj.org/article/1b20d8b963164253ae77af7bc2dd6e74
Autor:
Cole R. Clifford, Richard G. Jung, Benjamin Hibbert, Aun Yeong Chong, Marie Lordkipanidzé, Jean-Francois Tanguay, Derek Y.F. So
Publikováno v:
Platelets, Vol 33, Iss 2, Pp 298-303 (2022)
Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor is prescribed for 1-year after myocardial infarction. Two clinical strategies are considered at 1-year: continuation of DAPT or “Dual Pathway” (DP), using aspirin and rivaroxaban
Externí odkaz:
https://doaj.org/article/063e52ed46b04ab1a20537e66304a4be
Autor:
Trevor Simard, MD, Richard G. Jung, PhD, Pietro Di Santo, MD, David T. Harnett, MD, MSc, Omar Abdel-Razek, MD, F. Daniel Ramirez, MD, MSc, Pouya Motazedian, MD, Simon Parlow, MD, Alisha Labinaz, BSc, Robert Moreland, MD, Jeffrey Marbach, MBBS, MS, Anthony Poulin, MD, Amos Levi, MD, Kamran Majeed, MD, Paul Boland, MD, PhD, Etienne Couture, MD, Kiran Sarathy, MD, Steven Promislow, MD, Juan J. Russo, MD, Aun Yeong Chong, MD, Derek So, MD, Michael Froeschl, MD, Alexander Dick, MD, Marino Labinaz, MD, Michel Le May, MD, David R. Holmes, Jr., MD, Benjamin Hibbert, MD, PhD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 6, Pp 1138-1152 (2021)
Objective: To ensure compliance with optimal secondary prevention strategies and document the residual risk of patients following revascularization, we established a postrevascularization clinic for risk-factor optimization at 1 year, with outcomes r
Externí odkaz:
https://doaj.org/article/6b289dc2bcfd4552b2c9a6a2d127349c
Autor:
Quinton Barry, BMBS, FRCPC, Angel Fu, MD, FRCPC, Rene Boudreau, MD, FRCPC, Alyssa Chow, BSc, Cole Clifford, BSc, Trevor Simard, MD, FRCPC, Aun Yeong Chong, MBBS, FRCPC, Alexander Dick, MD, FRCPC, Michael Froeschl, MD, FRCPC, Christopher Glover, MD, FRCPC, Benjamin Hibbert, MD, FRCPC, Marino Labinaz, MD, FRCPC, Michel Le May, MD, FRCPC, FACC, Juan Russo, MD, FRCPC, Derek So, MD, FRCPC, FACC
Publikováno v:
CJC Open, Vol 3, Iss 9, Pp 1091-1099 (2021)
Background: De-escalation from potent platelet P2Y12 inhibitors to clopidogrel is common. Despite having a clinical rationale, non-bleeding-related de-escalation when a lateral change between potent agents is an option may put patients at increased i
Externí odkaz:
https://doaj.org/article/363a50dc866a424e92fd98a7e54d5f31
Autor:
Pietro Di Santo, Rebecca Mathew, Richard G. Jung, Trevor Simard, Stephanie Skanes, Brennan Mao, F. Daniel Ramirez, Jeffrey A. Marbach, Omar Abdel-Razek, Pouya Motazedian, Simon Parlow, Kevin E. Boczar, Gianni D’Egidio, Steven Hawken, Jordan Bernick, George A. Wells, Alexander Dick, Derek Y. So, Christopher Glover, Juan J. Russo, Caroline McGuinty, Benjamin Hibbert, the CAPITAL DOREMI investigators
Publikováno v:
Critical Care, Vol 25, Iss 1, Pp 1-11 (2021)
Abstract Background Cardiogenic shock (CS) is associated with significant morbidity and mortality. The impact of beta-blocker (BB) use on patients who develop CS remains unknown. We sought to evaluate the clinical outcomes and hemodynamic response pr
Externí odkaz:
https://doaj.org/article/892e9e082cce43ada4fdb355610c6730